1 NCCN (2019) National Comprehensive Cancer Network: Non Small-Cell Lung Cancer. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines):Version 7.2019
2 Guckenberger M, Aerts JG, Van Schil P, Weder W (2019) The American Society of Clinical Oncology-endorsed American Society for Radiation Oncology Evidence-Based Guideline of stereotactic body radiotherapy for early-stage non-small cell lung cancer: An expert opinion. J Thorac Cardiovasc Surg 157:358-361
3 Guckenberger M, Andratschke N, Alheit H et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190:26-33
4 Guckenberger M, Andratschke N, Dieckmann K et al (2017) ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol 124:11-17
5 Febbo JA, Gaddikeri RS, Shah PN (2018) Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Primer for Radiologists. Radiographics 38:1312-1336
6 Guckenberger M, Klement RJ, Allgauer M et al (2016) Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. Radiother Oncol 118:485-491
7 Guckenberger M, Klement RJ, Kestin LL et al (2013) Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 85:1074-1081
8 Okubo M, Itonaga T, Saito T et al (2017) Predicting risk factors for radiation pneumonitis after stereotactic body radiation therapy for primary or metastatic lung tumours. Br J Radiol 90:20160508
9 Zhao J, Yorke ED, Li L et al (2016) Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies. Int J Radiat Oncol Biol Phys 95:1357-1366
10 Knoll MA, Salvatore M, Sheu RD et al (2016) The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changes. Quant Imaging Med Surg 6:35-41
11 Inoue T, Shiomi H, Oh RJ (2015) Stereotactic body radiotherapy for Stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis. J Radiat Res 56:727-734
12 Ricardi U, Filippi AR, Guarneri A et al (2009) Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy. Acta Oncol 48:571-577
13 Baumann R, Chan MKH, Pyschny F et al (2018) Clinical Results of Mean GTV Dose Optimized Robotic-Guided Stereotactic Body Radiation Therapy for Lung Tumors. Front Oncol 8:171
14 Nakamura M, Nishikawa R, Mayahara H et al (2019) Pattern of recurrence after CyberKnife stereotactic body radiotherapy for peripheral early non-small cell lung cancer. J Thorac Dis 11:214-221
15 Aerts HJ, Velazquez ER, Leijenaar RT et al (2014) Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun 5:4006
16 Coroller TP, Agrawal V, Huynh E et al (2017) Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC. J Thorac Oncol 12:467-476
17 Coroller TP, Agrawal V, Narayan V et al (2016) Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol 119:480-486
18 Coroller TP, Grossmann P, Hou Y et al (2015) CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiother Oncol 114:345-350
19 Grove O, Berglund AE, Schabath MB et al (2015) Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma. PLoS One 10:e0118261
20 Lee G, Lee HY, Park H et al (2017) Radiomics and its emerging role in lung cancer research, imaging biomarkers and clinical management: State of the art. Eur J Radiol 86:297-307
21 Baek S, He Y, Allen BG et al (2019) Deep segmentation networks predict survival of non-small cell lung cancer. Sci Rep 9:17286
22 Dissaux G, Visvikis D, Do-Ano R et al (2019) Pre-treatment (18)F-FDG PET/CT Radiomics predict local recurrence in patients treated with stereotactic radiotherapy for early-stage non-small cell lung cancer: a multicentric study. J Nucl Med. 10.2967/jnumed.119.228106
23 Franceschini D, Cozzi L, De Rose F et al (2019) A radiomic approach to predicting nodal relapse and disease-specific survival in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. Strahlenther Onkol. 10.1007/s00066-019-01542-6
24 Huynh E, Coroller TP, Narayan V et al (2016) CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer. Radiother Oncol 120:258-266
25 Huynh E, Coroller TP, Narayan V et al (2017) Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT. PLoS One 12:e0169172
26 Lafata KJ, Hong JC, Geng R et al (2019) Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy. Phys Med Biol 64:025007
27 Li H, Galperin-Aizenberg M, Pryma D, Simone CB, 2nd, Fan Y (2018) Unsupervised machine learning of radiomic features for predicting treatment response and overall survival of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy. Radiother Oncol 129:218-226
28 Li Q, Kim J, Balagurunathan Y et al (2017) Imaging features from pretreatment CT scans are associated with clinical outcomes in nonsmall-cell lung cancer patients treated with stereotactic body radiotherapy. Med Phys 44:4341-4349
29 Li Q, Kim J, Balagurunathan Y et al (2017) CT imaging features associated with recurrence in non-small cell lung cancer patients after stereotactic body radiotherapy. Radiat Oncol 12:158
30 Li S, Yang N, Li B et al (2018) A pilot study using kernelled support tensor machine for distant failure prediction in lung SBRT. Med Image Anal 50:106-116
31 Oikonomou A, Khalvati F, Tyrrell PN et al (2018) Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy. Sci Rep 8:4003
32 Starkov P, Aguilera TA, Golden DI et al (2019) The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy. Br J Radiol 92:20180228
33 Takeda K, Takanami K, Shirata Y et al (2017) Clinical utility of texture analysis of 18F-FDG PET/CT in patients with Stage I lung cancer treated with stereotactic body radiotherapy. J Radiat Res. 10.1093/jrr/rrx050:1-8
34 Yu W, Tang C, Hobbs BP et al (2017) Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 10.1016/j.ijrobp.2017.10.046
35 van Timmeren JE, Carvalho S, Leijenaar RTH et al (2019) Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics. PLoS One 14:e0217536
36 Bousabarah K, Temming S, Hoevels M et al (2019) Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy. Strahlenther Onkol 195:830-842
37 Schmitt D, Blanck O, Gauer T et al (2020) Technological quality requirements for stereotactic radiotherapy : Expert review group consensus from the DGMP Working Group for Physics and Technology in Stereotactic Radiotherapy. Strahlenther Onkol 196:421-443
38 Stera S, Balermpas P, Chan MKH et al (2018) Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis. Strahlenther Onkol 194:143-155
39 Temming S, Kocher M, Stoelben E et al (2018) Risk-adapted robotic stereotactic body radiation therapy for inoperable early-stage non-small-cell lung cancer. Strahlenther Onkol 194:91-97
40 Wilke L, Andratschke N, Blanck O et al (2019) ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams : Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol 195:193-198
41 Dahele M, Palma D, Lagerwaard F, Slotman B, Senan S (2011) Radiological changes after stereotactic radiotherapy for stage I lung cancer. J Thorac Oncol 6:1221-1228
42 Trovo M, Linda A, El Naqa I, Javidan-Nejad C, Bradley J (2010) Early and late lung radiographic injury following stereotactic body radiation therapy (SBRT). Lung Cancer 69:77-85
43 Van Griethuysen JJ, Fedorov A, Parmar C et al (2017) Computational radiomics system to decode the radiographic phenotype. Cancer research 77:e104-e107
44 Zwanenburg A, Leger S, Löck S (2016) Image biomarker standardisation initiative. http://arxivorg/abs/161207003:Accessed January 2, 2020
45 Pölsterl S, Gupta P, Wang L, Conjeti S, Katouzian A, Navab N (2016) Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients. F1000Research 5
46 Cox DR (1972) Regression models and life‐tables. Journal of the Royal Statistical Society: Series B (Methodological) 34:187-202
47 Tsoutsou PG, Koukourakis MI (2006) Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys 66:1281-1293
48 Wang S, Campbell J, Stenmark MH et al (2017) Plasma Levels of IL-8 and TGF-beta1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study. Int J Radiat Oncol Biol Phys 98:615-621
49 Grossmann P, Stringfield O, El-Hachem N et al (2017) Defining the biological basis of radiomic phenotypes in lung cancer. Elife 6:e23421
50 Tang C, Hobbs B, Amer A et al (2018) Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer. Sci Rep 8:1922
51 Liang B, Yan H, Tian Y et al (2019) Dosiomics: Extracting 3D Spatial Features From Dose Distribution to Predict Incidence of Radiation Pneumonitis. Front Oncol 9:269
52 Diamant A, Chatterjee A, Faria S et al (2018) Can dose outside the PTV influence the risk of distant metastases in stage I lung cancer patients treated with stereotactic body radiotherapy (SBRT)? Radiother Oncol. 10.1016/j.radonc.2018.05.012
53 Hao H, Zhou Z, Li S et al (2018) Shell feature: a new radiomics descriptor for predicting distant failure after radiotherapy in non-small cell lung cancer and cervix cancer. Phys Med Biol 63:095007
54 Lou B, Doken S, Zhuang T et al (2019) An image-based deep learning framework for individualizing radiotherapy dose. Lancet Digit Health 1:e136-e147
55 Zhang Y, Oikonomou A, Wong A, Haider MA, Khalvati F (2017) Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer. Sci Rep 7:46349
56 Luo Y, McShan DL, Matuszak MM et al (2018) A multiobjective Bayesian networks approach for joint prediction of tumor local control and radiation pneumonitis in nonsmall-cell lung cancer (NSCLC) for response-adapted radiotherapy. Med Phys. 10.1002/mp.13029